How does G6PD deficiency affect newborn jaundice?

G6PD (glucose-6-phosphate dehydrogenase) deficiency is an X-linked enzyme disorder that impairs the ability of red blood cells to protect against oxidative stress, leading to hemolysis. In newborns, G6PD deficiency can cause unexpectedly rapid and severe bilirubin rises, sometimes without the typical gradual increase seen in physiologic jaundice. It is the leading single-gene cause of kernicterus worldwide. G6PD deficiency is most prevalent in populations of African, Mediterranean, Middle Eastern, and Southeast Asian ancestry. Screen early and treat with lower phototherapy thresholds.

What are normal bilirubin levels in newborns?

Bilirubin levels rise physiologically in all newborns after birth. 'Normal' levels are hour-specific: at 24h, a TSB below the 40th percentile (roughly <6–8 mg/dL) is low risk; at 48h, <10–11 mg/dL is low risk; at 72h, <12–13 mg/dL is low risk for most term infants. These are approximations — the Bhutani nomogram provides the precise percentile for any given age and TSB combination. The key is the risk zone, not a single cutoff number.

When is exchange transfusion needed for newborn jaundice?

Exchange transfusion is indicated when TSB reaches the exchange transfusion threshold despite intensive phototherapy, or when there are acute signs of bilirubin encephalopathy (lethargy, hypotonia, high-pitched cry, arching). The AAP 2022 guidelines provide exchange transfusion threshold nomograms, set approximately 5 mg/dL above phototherapy thresholds. For a term infant at 72h without risk factors, exchange transfusion is typically considered at TSB approaching 25 mg/dL. Exchange transfusion replaces ~85% of the infant's blood volume, removing bilirubin and hemolytic antibodies.

What are the AAP 2022 bilirubin guidelines?

The 2022 AAP hyperbilirubinemia guidelines (Kemper et al., Pediatrics 2022) introduced several updates from the 2004 guidelines: (1) Removed race/ethnicity as a risk factor, replacing it with specific neurotoxicity risk factors; (2) Provided updated phototherapy and exchange transfusion nomograms stratified by gestational age and neurotoxicity risk; (3) Strengthened recommendations for universal predischarge bilirubin screening; (4) Emphasized systematic structured follow-up planning linked to the Bhutani risk zone at discharge; (5) Updated guidance on TcB vs TSB measurement.

How long does newborn jaundice last?

Physiologic jaundice in term infants typically peaks at days 3–5 and resolves by day 7–10 of life. In preterm infants, it peaks at days 5–7 and may persist longer (up to 2–3 weeks). Breastfeeding jaundice (inadequate intake) resolves with improved feeding. Breast milk jaundice (late onset) can persist for 3–6 weeks but is generally benign. Persistent jaundice beyond 2–3 weeks in term infants warrants evaluation for pathological causes including biliary atresia, hypothyroidism, and hemolytic diseases.

How is kernicterus prevented?

Kernicterus prevention relies on: (1) Universal predischarge bilirubin screening before hospital discharge; (2) Risk zone–guided follow-up with specific timing tied to the Bhutani nomogram zone; (3) Parental education about jaundice warning signs at discharge; (4) Timely phototherapy initiation when thresholds are reached; (5) Exchange transfusion for failure of phototherapy or signs of acute bilirubin encephalopathy. Countries with systematic universal screening programs (e.g., UK, USA) have seen dramatic reductions in kernicterus rates over the past 20 years.

Can the Bhutani nomogram be applied to premature infants under 35 weeks?

No. The Bhutani nomogram was derived from a cohort of healthy newborns ≥36 weeks gestational age. It is not validated for infants below 35 weeks, who require even lower phototherapy thresholds due to increased neurotoxicity vulnerability. For infants 35–37 weeks (late preterm), use the age-specific lower thresholds provided in the AAP 2022 guidelines. For infants <35 weeks, follow NICU-specific protocols based on gestational age and birth weight, typically starting phototherapy at TSB levels well below those used for term infants.

Online Medical Tools — Neonatal Bilirubin Risk

Printed on 6/30/2026

For informational purposes only. This is not medical advice.

Pediatrics

Neonatal Bilirubin Risk

The Neonatal Bilirubin Risk calculator plots a newborn's total serum bilirubin (TSB) against their age in hours on the Bhutani nomogram to determine risk zone for subsequent significant hyperbilirubinemia. Risk zones are: Low Risk (<40th percentile), Low-Intermediate (40th–75th), High-Intermediate (75th–95th), and High Risk (≥95th percentile). This guides follow-up timing and phototherapy decisions. The AAP recommends universal bilirubin screening before discharge and risk-based follow-up. Failure to identify and treat severe neonatal jaundice can lead to kernicterus (bilirubin encephalopathy). For comprehensive newborn assessment, use [Apgar Score](/tools/apgar-score). In the emergency setting, estimate drug doses with [APLS Weight Estimate](/tools/apls-weight) and [Pediatric Dose Calculator](/tools/pediatric-dose). For elevated bilirubin context, the liver handles bilirubin — see [MELD Score](/tools/meld-score) for liver function context in older patients.

Formula: Hour-specific bilirubin percentile thresholds (Bhutani nomogram, 1999).

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Obtain TSB and record exact age in hours

Obtain total serum bilirubin (TSB) in mg/dL from the laboratory and note the infant's exact age in hours from birth. Minor errors in age (using days instead of hours) can shift the risk zone assignment and lead to incorrect management decisions.

Plot on the Bhutani nomogram risk zones

Plot the TSB against age in hours on the Bhutani nomogram. The nomogram divides results into four zones: Low zone (<40th percentile), Low-Intermediate zone (40th–75th percentile), High-Intermediate zone (75th–95th percentile), and High Risk zone (>95th percentile). Each zone carries a different probability of subsequent severe hyperbilirubinemia.

Apply risk factors to determine follow-up and phototherapy threshold

High zone = high risk for severe hyperbilirubinemia requiring immediate evaluation for phototherapy. High-Intermediate zone = follow-up within 24–48 hours after discharge. Phototherapy thresholds vary by gestational age, age in hours, and neurotoxicity risk factors (G6PD deficiency, isoimmune hemolytic disease, albumin <3 g/dL, prior sibling requiring phototherapy). Refer to the AAP 2022 phototherapy nomogram for precise thresholds.

Who Uses the Neonatal Bilirubin Risk

Newborn Nursery Jaundice Triage

Pediatricians & Neonatologists

Routine pre-discharge bilirubin screening in all newborns ≥35 weeks gestational age. The Bhutani nomogram provides an objective, evidence-based risk zone that guides whether the infant can be safely discharged or requires phototherapy evaluation before leaving the hospital. Combined with clinical risk factors, it eliminates reliance on visual assessment of jaundice depth, which is unreliable across all skin tones.

Phototherapy Initiation Decisions

Neonatology Teams & Hospitalists

Determines when to initiate phototherapy by integrating bilirubin level, age in hours, gestational age, and neurotoxicity risk factors. The AAP 2022 guidelines provide phototherapy threshold nomograms that depend directly on the Bhutani risk zone assignment. High-risk zone infants with neurotoxicity risk factors often meet phototherapy criteria at lower absolute TSB levels than low-risk term infants.

Follow-Up Timing After Early Discharge

Maternity Ward & Pediatric Nurses

Infants discharged before 72 hours of age — when physiologic bilirubin peaks are still rising — need structured follow-up. The nomogram zone at discharge determines urgency: Low zone = follow-up in 48–72 hours; High-Intermediate zone = follow-up within 24 hours. Early discharge without risk-stratified follow-up planning is a key driver of preventable kernicterus cases.

Identifying Neonates Needing Exchange Transfusion Workup

NICU Teams

Infants who fail phototherapy or present with rapidly rising bilirubin approaching exchange transfusion thresholds require urgent NICU evaluation. The Bhutani nomogram, combined with rate of rise calculation, helps identify these infants early. Exchange transfusion is indicated when TSB reaches approximately 25 mg/dL at 48–72h in term infants without risk factors, lower with neurotoxicity risk factors.

Population-Level Jaundice Quality Monitoring

Quality Improvement Teams

Hospital quality programs use universal pre-discharge bilirubin screening data plotted on the Bhutani nomogram to track rates of high-risk discharges, phototherapy initiation, and readmissions for jaundice. This supports Joint Commission and AAP compliance, identifies gaps in follow-up protocols, and benchmarks outcomes against national neonatal jaundice prevention standards.

Primary Care Follow-Up in the First Week of Life

Family Medicine & Pediatric Outpatient Clinicians

Newborns seen at the mandatory 2–4 day follow-up visit often receive transcutaneous bilirubin (TcB) measurement. TcB values can be plotted on the nomogram to determine whether formal TSB confirmation is needed. Any TcB within 3 mg/dL of the phototherapy threshold requires confirmatory serum TSB. This outpatient application of the nomogram is especially critical for exclusively breastfed infants.

Pro Tips

Jaundice in first 24 hours is always pathological

Any visible jaundice appearing within the first 24 hours of life is never physiologic — always investigate urgently. Common causes include ABO incompatibility, Rh hemolytic disease, G6PD deficiency, and sepsis. Obtain TSB immediately, blood type, direct Coombs test, CBC with differential, and reticulocyte count. Do not wait for the 24-hour mark to act on clinical jaundice in the first day of life.

Age in HOURS — not days — determines risk zone

The Bhutani nomogram is hour-specific. A bilirubin of 14 mg/dL at 36 hours falls in a very different zone than the same value at 96 hours. Using 'day 2' instead of '48 hours' introduces errors that change zone assignment. Always document and enter the exact age in hours from birth, calculated from the delivery timestamp in the medical record, not estimated from the calendar day.

Neonatal bilirubin has a normal physiologic peak

Term infants (38–40 weeks) typically peak at 3–5 days of life. Preterm infants (35–37 weeks) peak at 5–7 days. This means bilirubin is still rising at the time most infants are discharged (24–48 hours). Always predict the trajectory, not just the current level — a baby at the Low-Intermediate zone at 36 hours may still rise into a higher zone at 72–96 hours of life.

Phototherapy thresholds vary by gestational age

Preterm infants (35–37 weeks gestation) have a lower phototherapy threshold than full-term infants because immature blood-brain barrier and albumin binding capacity increase risk of bilirubin neurotoxicity at lower TSB levels. The AAP 2022 updated guidelines provide separate phototherapy nomograms for infants with and without neurotoxicity risk factors, replacing the single fixed threshold approach.

G6PD deficiency dramatically escalates risk

G6PD (glucose-6-phosphate dehydrogenase) deficiency is the most common enzyme disorder worldwide and is prevalent in populations of Mediterranean, African, Southeast Asian, and Middle Eastern ancestry. It can cause rapid, unpredictable bilirubin rises and dramatically increases severe hyperbilirubinemia and kernicterus risk. Screen early in high-risk ethnic groups, and treat G6PD-positive infants with lower phototherapy thresholds and more aggressive monitoring even in Low-Intermediate zone.

AAP 2022 removed race as a risk factor

The 2022 AAP hyperbilirubinemia update (Kemper et al., Pediatrics 2022) explicitly removed race and ethnicity from neurotoxicity risk factor assessment, replacing it with specific, evidence-based risk factors: G6PD deficiency, isoimmune hemolytic disease (positive DAT), albumin <3 g/dL, and prior sibling requiring phototherapy. This change reflects AAP's commitment to eliminating race-based medicine while maintaining appropriate clinical risk stratification.

Always check blood type and Coombs test if mother is O or Rh-negative

ABO incompatibility (mother O, baby A or B) and Rh incompatibility (Rh-negative mother sensitized to Rh-positive infant) are major causes of hemolytic jaundice requiring early, aggressive management. Direct antiglobulin test (DAT/Coombs) should be obtained at birth if mother is type O or Rh-negative. Positive Coombs test is a neurotoxicity risk factor that lowers phototherapy threshold.

Discharge before 24 hours requires same-day follow-up

Infants discharged before 24 hours of life must have a same-day or next-morning follow-up appointment scheduled at discharge. The earlier the discharge, the higher the bilirubin monitoring burden — these infants have not yet reached their physiologic peak. Document the specific follow-up plan in the discharge paperwork, and confirm parents understand warning signs: yellow sclera or skin, poor feeding, high-pitched cry, extreme sleepiness.

Adequate breastfeeding reduces bilirubin

Breastfeeding jaundice (early onset, days 2–5) is caused by inadequate caloric and fluid intake — the dehydrated infant has less gut motility, more bilirubin reabsorption, and reduced excretion. Assess latch, feeding frequency (every 2–3 hours, 8–12 times/day), and weight loss (<10% acceptable). Supplementation with expressed breast milk or formula is appropriate if there is significant weight loss or poor feeding. Breastfeeding jaundice is distinct from breast milk jaundice (late onset, weeks 2–3).

Kernicterus is preventable with timely management

Kernicterus (bilirubin-induced neurological dysfunction, BIND) is a devastating and largely preventable complication. It requires extreme hyperbilirubinemia (typically >25–30 mg/dL) but can occur at lower levels in preterm or high-risk infants. Early clinical signs (acute bilirubin encephalopathy) include lethargy, hypotonia, poor feeding, then arching, high-pitched cry, fever, and opisthotonus. Universal pre-discharge screening and structured follow-up per AAP guidelines have dramatically reduced kernicterus incidence in countries with universal screening programs.

Common Questions About Your Results

Using days instead of hours is the most common and consequential error with the Bhutani nomogram. A bilirubin measured at 48 hours entered as '2 days' may be interpreted correctly in some calculators, but any ambiguity leads to incorrect zone assignment. A bilirubin of 12 mg/dL at 24 hours is High-Intermediate risk; the same value at 72 hours is Low-Intermediate. Always convert to hours explicitly from the documented birth time in the medical record.

No. Preterm infants (35–36 weeks gestation, sometimes called 'late preterm') are more vulnerable to bilirubin neurotoxicity at lower TSB levels. They have lower albumin binding capacity, more immature blood-brain barriers, and greater feeding difficulties leading to higher bilirubin levels. The AAP 2022 guidelines provide separate lower phototherapy thresholds for late preterm infants with neurotoxicity risk factors. Never apply term thresholds to an infant less than 38 weeks gestational age.

G6PD deficiency can cause dramatic, rapid bilirubin rises with oxidative triggers (infections, certain medications, fava beans in breast milk). When an infant returns with unexpectedly high or rapidly rising bilirubin, G6PD testing should be obtained immediately alongside the bilirubin workup. In G6PD-deficient infants, phototherapy should be initiated aggressively and exchange transfusion threshold lowered. Screen proactively in populations with high G6PD prevalence: West African, Mediterranean, Middle Eastern, and Southeast Asian ancestry.

High-Intermediate zone (75th–95th percentile) infants have a meaningful risk of subsequent severe hyperbilirubinemia and should not be discharged without a clearly documented follow-up plan within 24 hours. If discharge is necessary, ensure parents understand warning signs (increasing yellowing, poor feeding, high-pitched cry, hard to wake), the exact follow-up time and location, and that they should return immediately if concerned. Some institutions admit High-Intermediate infants with additional risk factors for observation and repeat bilirubin in 6–12 hours.

TcB is a noninvasive screening tool that correlates reasonably well with TSB but can be unreliable after phototherapy and in deeply pigmented skin. TcB should be confirmed with serum TSB if the TcB is within 3 mg/dL of the phototherapy threshold, if values seem unexpectedly high or low, or after phototherapy (which bleaches the skin and falsely lowers TcB). The Bhutani nomogram and AAP phototherapy thresholds are calibrated to TSB — always convert TcB to TSB before making phototherapy decisions in borderline cases.

Evidence-Based Methodology

Bhutani nomogram published by Bhutani et al. (Pediatrics 1999) from 2840 newborns ≥36 weeks. High zone (>95th percentile) predicted 40% risk of subsequent severe hyperbilirubinemia (TSB >17 mg/dL). AAP Hyperbilirubinemia Guidelines 2004 (Subcommittee on Hyperbilirubinemia) and 2022 update (Kemper et al., Pediatrics 2022) incorporate the nomogram for risk stratification and phototherapy initiation. The 2022 update removed race/ethnicity as a risk factor and added specific neurotoxicity risk factors.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Your newborn's bilirubin level is plotted against their age in hours to determine the risk zone on the Bhutani nomogram. The Low Risk zone (below the 40th percentile) indicates a very low likelihood of subsequent significant hyperbilirubinemia. The Low-Intermediate zone (40th-75th percentile) carries a small but real risk. The High-Intermediate zone (75th-95th percentile) indicates moderate risk and warrants close follow-up within 24-48 hours. The High Risk zone (above the 95th percentile) indicates significant risk and usually requires immediate evaluation for phototherapy.

The risk zone helps determine how soon after discharge the infant needs a follow-up bilirubin check. High-risk zone infants may need follow-up within 24 hours or may require phototherapy before discharge. Low-risk zone infants may safely have follow-up in 48-72 hours. These timelines should be adjusted based on additional risk factors such as prematurity, hemolysis, and breastfeeding status.

When to Use This Tool

Use this tool for all newborns as part of the universal pre-discharge bilirubin screening recommended by the American Academy of Pediatrics (AAP). It is most commonly applied at 24-72 hours of life when a total serum bilirubin or transcutaneous bilirubin measurement is obtained. It is especially important for infants being discharged before 72 hours of age, as bilirubin levels typically peak at 3-5 days of life.

This tool is also useful at follow-up visits in the first week of life to reassess bilirubin trajectory and determine whether phototherapy thresholds are being approached.

Limitations

The Bhutani nomogram was developed from a specific population of healthy term and near-term newborns (gestational age 36 weeks or greater) and may not be directly applicable to premature infants below 35 weeks gestational age, who have lower phototherapy thresholds. The nomogram predicts the risk of subsequent hyperbilirubinemia but does not itself determine phototherapy thresholds — the AAP phototherapy guidelines are a separate tool.

A single bilirubin measurement in the low-risk zone does not guarantee the infant will not develop significant jaundice, particularly if risk factors are present (ABO incompatibility, G6PD deficiency, significant bruising, poor feeding). Clinical judgment and appropriate follow-up remain essential regardless of the risk zone result.

For related assessments, see Apgar Score, Pediatric Weight Estimate and Pediatric GCS.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Obstetrics

Apgar Score

Calculate the Apgar Score to quickly assess newborn health at 1 and 5 minutes after birth. Evaluates appearance, pulse, grimace, activity, and respiration.

Open Pediatrics

Pediatric Weight Estimate

Estimate pediatric weight by age using APLS formulas (ages 1–5: 2×age+8 kg; ages 6–14: 3×age+7 kg). Critical for emergency drug dosing and equipment sizing when a scale is unavailable.

Open Pediatrics

Pediatric GCS

Assess level of consciousness in infants and young children using the Pediatric Glasgow Coma Scale. Scores range from 3 to 15.

Open

Frequently Asked Questions

Neonatal jaundice (neonatal hyperbilirubinemia) is the yellow discoloration of a newborn's skin and sclerae caused by elevated total serum bilirubin (TSB). It occurs in approximately 60% of term and 80% of preterm newborns in the first week of life. Bilirubin is produced from the breakdown of fetal hemoglobin (heme), and newborns produce more bilirubin than they can initially conjugate and excrete. Most cases are benign and self-limited, but severe hyperbilirubinemia can cause kernicterus — permanent neurological damage.

The Bhutani nomogram (Bhutani et al., Pediatrics 1999) plots TSB against age in hours and divides results into four zones: Low Risk (<40th percentile) — very unlikely to develop severe jaundice; Low-Intermediate (40th–75th percentile) — low but real risk, requires appropriate follow-up; High-Intermediate (75th–95th percentile) — meaningful risk, follow-up within 24 hours after discharge; High Risk (>95th percentile) — high risk for severe hyperbilirubinemia, evaluate for phototherapy immediately.

Phototherapy thresholds depend on the infant's age in hours, gestational age (35 weeks vs 38+ weeks), and neurotoxicity risk factors (G6PD deficiency, isoimmune hemolytic disease, albumin <3 g/dL, prior sibling requiring phototherapy). The AAP 2022 guidelines provide updated phototherapy nomograms for infants with and without these risk factors. For a term infant (≥38 weeks) without risk factors, phototherapy is typically indicated at approximately TSB 17–18 mg/dL at 48h and 19–20 mg/dL at 72h. Thresholds are substantially lower for preterm infants and those with neurotoxicity risk factors.

The AAP 2022 neurotoxicity risk factors that lower phototherapy thresholds include: G6PD deficiency, isoimmune hemolytic disease (positive direct antiglobulin test/Coombs), serum albumin <3 g/dL, and prior sibling who received phototherapy. Additional factors that increase jaundice risk overall include: gestational age 35–37 weeks (late preterm), exclusive breastfeeding with >10% weight loss, cephalohematoma or significant bruising, and visible jaundice in the first 24 hours of life. Race/ethnicity was removed as a risk factor in the 2022 update.

Yes — any visible jaundice appearing within the first 24 hours of life is considered pathological and requires immediate investigation. Physiologic jaundice does not appear until day 2 or later. Early-onset jaundice suggests hemolysis (ABO incompatibility, Rh disease, G6PD deficiency), infection/sepsis, or polycythemia. Obtain TSB urgently (do not wait), blood type, direct Coombs test, CBC with differential, and reticulocyte count. Early-onset jaundice is one of the strongest predictors of subsequent severe hyperbilirubinemia.

Phototherapy thresholds are age-specific (in hours) and risk-stratified. There is no single universal cutoff. The AAP 2022 guidelines provide downloadable phototherapy threshold nomograms. As a general reference: at 24h — threshold approximately 10–12 mg/dL (risk factors) to 13–15 mg/dL (no risk factors); at 48h — approximately 15–16 mg/dL (risk factors) to 17–18 mg/dL (no risk factors); at 72h — approximately 17–18 mg/dL (risk factors) to 19–21 mg/dL (no risk factors). Always use the AAP 2022 nomogram for specific clinical decisions.

Online Medical Tools — Neonatal Bilirubin Risk

Printed on 6/30/2026

For informational purposes only. This is not medical advice.

Pediatrics

Neonatal Bilirubin Risk

Formula: Hour-specific bilirubin percentile thresholds (Bhutani nomogram, 1999).

Age of Newborn

hours

Total Serum Bilirubin

mg/dL

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Obtain TSB and record exact age in hours

Plot on the Bhutani nomogram risk zones

Apply risk factors to determine follow-up and phototherapy threshold

Who Uses the Neonatal Bilirubin Risk

Newborn Nursery Jaundice Triage

Pediatricians & Neonatologists

Phototherapy Initiation Decisions

Neonatology Teams & Hospitalists

Follow-Up Timing After Early Discharge

Maternity Ward & Pediatric Nurses

Identifying Neonates Needing Exchange Transfusion Workup

NICU Teams

Population-Level Jaundice Quality Monitoring

Quality Improvement Teams

Primary Care Follow-Up in the First Week of Life

Family Medicine & Pediatric Outpatient Clinicians

Pro Tips

Jaundice in first 24 hours is always pathological

Age in HOURS — not days — determines risk zone

Neonatal bilirubin has a normal physiologic peak

Phototherapy thresholds vary by gestational age

G6PD deficiency dramatically escalates risk

AAP 2022 removed race as a risk factor

Always check blood type and Coombs test if mother is O or Rh-negative

Discharge before 24 hours requires same-day follow-up

Adequate breastfeeding reduces bilirubin

Kernicterus is preventable with timely management

Common Questions About Your Results

Evidence-Based Methodology

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

When to Use This Tool

This tool is also useful at follow-up visits in the first week of life to reassess bilirubin trajectory and determine whether phototherapy thresholds are being approached.

Limitations

For related assessments, see Apgar Score, Pediatric Weight Estimate and Pediatric GCS.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Obstetrics